Indonesia Cardiovascular Diseases Therapeutics Market Analysis

Indonesia Cardiovascular Diseases Therapeutics Market Analysis


$ 3999

The Indonesia cardiovascular disease therapeutics is projected to grow from $976 Mn in 2022 to $1,706 Mn in 2030 with a CAGR of 7.22% for the year 2022-2030. Rapid urbanization leading to shifting lifestyle behaviours in the population of Indonesia resulting in the increased incidence of cardiovascular diseases is responsible for the growth of the market. The Indonesia cardiovascular disease therapeutics market is segmented by disease indication, drug type, route of administration, drug classification, mode of purchase, and by the end user. Combiphar, Ivosights, and Bayer are the major players in the Indonesia cardiovascular disease therapeutics market.

ID: IN10IDPH033 CATEGORY: Pharmaceuticals GEOGRAPHY: Indonesia AUTHOR: Dr. Parul Choudhary

Buy Now

Indonesia Cardiovascular Disease Therapeutics Market Executive Analysis

The Indonesia cardiovascular disease therapeutics market size is at around $976 Mn in 2022 and is projected to reach $1,706 Mn in 2030, exhibiting a CAGR of 7.22% during the forecast period. In 2023, the Indonesian ministry will put aside $5.96 billion of the $11 Bn total health budget for health transformation. The transformation of primary services through public education, primary prevention, and secondary prevention, as well as boosting the capacity and competence of primary services, will be accomplished with the aid of $4 Bn, according to the minister. Additionally, $1.2 Bn will be allocated for the transformation of referral services through enhancements to intermediate and tertiary services' accessibility and quality. $96 Mn is allocated for the health security system to strengthen disaster preparedness and the resiliency of the pharmaceutical and medical device industries.

In Indonesia, cardiovascular disease (CVD) is responsible for about one-third of all fatalities, with coronary heart disease (CHD) and stroke being among the top fatalities there. According to estimates, stroke and coronary heart disease (CHD) account for more than 470 000 yearly fatalities in Indonesia. The most popular method for removing clots and restoring blood vessel endothelial membrane elasticity is statin treatment. Aspirin is also the medication that Indonesians use the most frequently for the secondary prevention of CVDs. International recommendations on the primary prevention of CVDs only suggest aspirin if the risk of cardiac events persists for at least 10 years due to aspirin's reported increased risk of bleeding.

Nanomedicine is a convergent science that modifies disease treatment and diagnosis by fusing the disciplines of biology, biochemistry, physics, engineering, genetics, and biotechnology. The problems with the currently used traditional stents are being addressed by the investigation of nano polymeric-coated biodegradable stents. These innovative stents can lessen platelet adhesion rates and enhance drug release characteristics. Extensive study is being done on nanomedicines with various properties and compositions for the treatment of CVDs in Indonesia. They consist of polymeric nanoparticles (NPs), silica-based nanoconjugates, micelles, liposomes, liposomes, exosomes, metallic NPs, dendrimers, composite nanosystems, poly (ethylene glycol)-ated (PEGylated) nanospheres, and immunopurified nanoshells.

Indonesia Cardiovascular Disease Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers

In Indonesia, the prevalence of cardiovascular diseases is rising due to rapid urbanization and behavioural shifts like poor diets and insufficient exercise. To manage and treat these conditions, there is an increasing need for efficient cardiovascular disease therapeutics. To enhance the general health of its citizens, the Indonesian government has been increasing its spending on healthcare, including cardiovascular disease therapeutics. This increased spending is anticipated to fuel growth in the Indonesia cardiovascular disease therapeutics market. To increase access to healthcare, the Indonesian government established in place a few programs, including therapeutics for cardiovascular disease. For instance, the government has established a national health coverage program that gives access to reasonably priced healthcare services, such as therapeutics for cardiovascular disease.

Market Restraints

The healthcare system in Indonesia is still being built, especially in remote regions. This may restrict access to cardiovascular disease treatments, especially for people who live outside of big cities. The government's plan for comprehensive health coverage gives people access to reasonably priced medical services, including treatments for cardiovascular diseases. Access to some treatments, however, may be restricted by the reimbursement rules for these procedures. The cost of cardiovascular disease therapeutics can be expensive, especially for novel treatments. This may make these treatments less accessible, especially for those with restricted financial means restricting the growth of Indonesia's cardiovascular disease therapeutics market.

Competitive Landscape

Key Players

  • Pharos (IDN)
  • Etana Biotechnologies (IDN)
  • Herlina Indah (IDN)
  • Combiphar (IDN)
  • Ivosights (IDN)
  • Bayer
  • Sun Pharmaceutical
  • Novartis
  • Mylan
  • Teva Pharmaceutical
  • Zydus
  • Pfizer
  • Lupin

Healthcare Policies and Regulatory Landscape

The National Health Insurance (Jaminan Kesehatan Nasional or JKN) scheme, which was introduced in 2014 to provide universal healthcare coverage to all residents, mainly governs cardiovascular healthcare and reimbursement in Indonesia. All Indonesian citizens have access to essential healthcare services, including cardiovascular care, under the JKN program. Indonesia has been making investments to increase accessibility to high-quality cardiovascular care facilities. Improve the standard of care, this entails creating specialized cardiovascular centres and hospitals, expanding the pool of qualified medical personnel, and offering training and educational initiatives. The JKN scheme reimburses for a variety of medical services, including cardiovascular treatment. For some therapies or services, there might be restrictions on coverage and reimbursement rates. For some treatments, patients might also need to cover co-payments or other out-of-pocket costs.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Cardiovascular Disease Therapeutics Segmentation

By Disease Indication (Revenue, USD Billion):

  • Hypertension
  • Coronary Artery Disease
  • Hyperlipidaemia
  • Arrhythmia
  • Others

By Drug Type (Revenue, USD Billion):

  • Antihypertensive
  • Anticoagulants
  • Antihyperlipidemic
  • Antiplatelet Drugs
  • Others

By Route of Administration (Revenue, USD Billion):

  • Oral
  • Parenteral
  • Others

By Drug Classification (Revenue, USD Billion):

  • Branded Drugs
  • Generic Drugs

By Mode of Purchase (Revenue, USD Billion):

  • Prescription-Based Drugs
  • Over-The-Counter Drugs

By End Users (Revenue, USD Billion):

  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 05 April 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up